Congenital Lower Limb Deficiency Overview

Congenital lower limb deficiency includes a spectrum of femoral, fibular, tibial and foot deficiencies. The child may present at birth with an obvious short limb, missing rays or foot deformity, or later when gait asymmetry, shoe wear, brace difficulty or limb length discrepancy becomes apparent.

The visible discrepancy is only the surface problem. The real decision is whether the limb can become a stable, pain-free, efficient lever for walking.

The deficiency pattern reflects abnormal limb formation rather than a postnatal injury. Each diagnosis is a whole-limb pattern, not a single missing bone.

Limb length discrepancy commonly increases proportionally with growth. Segment contribution matters: femoral shortening, tibial shortening and reduced foot height all add to the final difference. The child also adapts: ball-and-socket ankle, pelvic obliquity, compensatory equinus, shoe lifts, brace reliance and altered gait may appear as growth progresses.

The lengthening biology is also abnormal. Short soft tissues, altered nerves and vessels, deficient muscles and unstable joints make repeated lengthening more hazardous than ordinary limb equalisation. This is why reconstruction planning starts with stability and foot function before the amount to lengthen.

Classifications are useful only if they guide treatment. For congenital femoral deficiency, classifications describe proximal femoral anatomy and reconstructability. For fibular hemimelia, older systems described fibular absence, but modern treatment planning places more weight on foot and ankle deformity, rays, coalition and stability. For tibial hemimelia, classifications describe the amount of tibia present and knee or ankle reconstructability.

Fibular deficiency: Achterman-Kalamchi, and why it is no longer enough

The classical description is the Achterman-Kalamchi classification, derived from 97 limbs in 81 patients:

• Type I — the fibula is present but hypoplastic. Type IA has a proximal fibular epiphysis lying distal to the proximal tibial physis and a distal fibular physis lying proximal to the talar dome; Type IB has 30 to 50 percent of the fibula missing, with the distal fibula failing to support the ankle.
• Type II — the fibula is completely absent, usually with a fibrous anlage running in its place.

Two findings from that original series still change practice, and both cut against intuition.

Femoral anomalies are commoner in the milder type, not the severer one — 76 percent in Type I against 59 percent in Type II. A modest-looking fibula therefore buys no reassurance about the femur, so image the whole limb in every case rather than reserving femoral assessment for complete absence.

Percentage shortening was fairly constant through growth — roughly 13 percent of limb length in Type I and 19 percent in Type II. This is the single most useful planning fact on the topic, because it means the discrepancy can be projected from one early measurement rather than waiting years for a trend.

The limitation of the classification is that it grades the bone that matters least to the decision. Reconstruction fails because of residual or recurrent foot deformity, not because of how much fibula is missing, which is why Paley's classification grades the ankle joint instead of the fibula and matches a named procedure to each pattern:

• A hypoplastic distal fibula with dynamic valgus — the ankle deviates under load but is not fixed — is addressed by the SHORDT procedure, shortening and realigning the distal tibia relative to the fibula.
• A fixed equinovalgus foot requires the SUPERankle procedure: a supramalleolar shortening-realignment osteotomy, with subtalar osteotomies and resection of the fibular anlage as needed.

Both correct through bone rather than soft tissue, which is what prevents recurrence, and shortening the tibia rather than lengthening tendons preserves gastro-soleus and peroneal power. Reconstruction advocates report that where a plantigrade, painless foot is achieved and serial lengthening follows, function compares well with a Syme amputation and prosthesis.

Be careful how you present that in an exam or a clinic, because the only pooled synthesis points the other way. The meta-analysis cited later on this page (Elmherig, 7 retrospective cohorts, 169 limbs) found amputation ahead on every outcome it could pool: patient satisfaction odds ratio 6.8 (CI 2.4 to 19.2), complications odds ratio 28 against reconstruction (CI 7.8 to 100.3), 1.2 versus 0.2 complications per limb, and 4.2 versus 1.5 operations per patient. The favourable reconstruction figures are conditioned on having achieved a plantigrade painless foot - which is the outcome in question, not a starting condition - whereas the pooled data count every child who set out down that path.

The two literatures are reconcilable once you separate the endpoints, and that is the answer to give. What is not in dispute is the burden of treatment: reconstruction costs roughly three times the operations and six times the complications per limb. Those are counts, not opinions. What is genuinely comparable is the destination: the dedicated comparative study on the fibular hemimelia page (Birch, 20 primary amputations against 22 staged reconstructions, assessed at a mean age of 9) found no significant functional or psychological difference, psychosocial and quality-of-life scores in both groups comparable to healthy populations, and the majority of patients and parents in both groups satisfied and willing to choose the same again - with the honest caveat that the groups differed socioeconomically as well as in treatment.

So the question is unsettled because the evidence is weak and the protocols are not uniform - Level III retrospective cohorts, obvious selection and reporting bias, no randomised comparison - not because reconstruction has been shown to cost nothing extra. Counsel on that split: a similar likely destination, reached by a much longer and more complicated road. A family that understands both and still wants the foot is making a defensible choice.

Tibial deficiency: the Jones classification, and the one question it answers

Tibial deficiency is graded by the Jones, Barnes and Lloyd-Roberts classification. It is worth knowing precisely, because the type determines whether a knee can be built at all — and the decisive distinction, between Type 1a and Type 1b, is invisible on a plain radiograph in an infant.

The 1a/1b distinction is the examinable one, and it is the reason you image before you decide. Both look like an absent tibia on a plain film of an infant. The size of the distal femoral epiphysis is the free clue on that same radiograph — hypoplastic in 1a, normal in 1b — and ultrasound or MRI then confirms whether a cartilaginous anlage exists. Getting this wrong in either direction is costly: a 1b disarticulated has lost a reconstructable knee, while a 1a offered reconstruction faces repeated surgery on a knee that was never going to extend.

Whatever the type, the functional question comes before the anatomical one: is there active knee extension? A tibia that can be reconstructed is of no use beneath a quadriceps that cannot work it, and this is why the examination finding of active knee extension carries more weight in tibial deficiency than any single radiographic feature.

View larger

History

Examination

Examine from pelvis to toes, then watch gait with and without the orthosis or prosthesis.

Radiographs should answer treatment questions. Full-length calibrated standing films, with an appropriate block under the short limb when possible, help measure segment lengths, mechanical axis and pelvic balance. Dedicated hip, knee, ankle and foot radiographs define reconstructability. In younger children, cartilage and unossified structures may limit plain film interpretation.

MRI is useful in selected cases: hip cartilage, knee cruciate absence, fibular anlage, subtalar coalition, soft tissue and vascular anomalies can all change reconstruction planning. CT may help complex foot and ankle or rotational planning but should be used selectively.

How the Prediction Is Actually Made

Naming three methods is not a plan; a viva will ask which one and why.

The multiplier method is the one to reach for in congenital deficiency, and the reason is specific to this group of conditions. In a congenital deficiency the short limb grows at a fixed proportion of the long limb, so the discrepancy expressed as a percentage of limb length stays essentially constant throughout growth — measured directly at about 13 percent for Achterman-Kalamchi Type I fibular deficiency and 19 percent for Type II. Because the ratio does not drift, a single reliable measurement at almost any age can be multiplied by an age-and-sex-specific factor to give the discrepancy at maturity. There is no need to accumulate years of serial films before committing to a strategy, which matters when the decision in front of you is whether an infant is heading for a Syme amputation or a reconstruction programme.

The two older methods answer a slightly different question and remain useful:

• The Green-Anderson growth-remaining charts estimate how much growth is left in each physis, which is what you need when timing an epiphysiodesis rather than predicting a congenital ratio.
• The Moseley straight-line graph plots serial measurements against skeletal age and converts the growth curves into straight lines, so a deviation from the line signals that growth is not behaving as assumed. It needs several measurements over time, which is precisely what the multiplier method avoids — but it is the better tool where growth may not be proportional, such as an acquired arrest after trauma, sepsis or physeal bar.

Two arithmetic anchors worth carrying: around the knee the distal femoral physis contributes roughly 9 to 10 mm of growth per year and the proximal tibial physis roughly 6 mm, so an epiphysiodesis at the knee removes on the order of 16 mm per remaining year. Getting the timing wrong by a year therefore costs more than a centimetre, in either direction.

Discrepancy Bands and What They Usually Mean

These are planning conventions rather than rules, and in congenital deficiency joint stability and foot function override them — but a candidate should be able to state them.

Do not forget foot height. The heel-to-floor contribution is part of the functional discrepancy and is easily omitted when segment lengths are measured off a radiograph, yet it is what the shoe raise or the prosthetic foot actually has to make up.

View larger

View larger

A short or deformed lower limb in a child is not always a longitudinal deficiency. The key task is to separate true congenital segmental deficiency from bowing, dysplasia, constriction and acquired growth arrest, because each has a different natural history and a different treatment pathway.

View larger

The first management step is not surgery. It is to explain the diagnosis, establish current function, predict future discrepancy and compare realistic pathways.

Lengthening can be highly effective in selected children, but it is not a passive increase in bone length. It stresses bone, joints, muscle, nerve, vessel, skin and family life. The major preventable errors are lengthening before joint stability is secured, ignoring foot deformity, underestimating soft-tissue tightness, and failing to plan rehabilitation.

Natural history complications

• Increasing limb length discrepancy.
• Progressive gait asymmetry and pelvic obliquity.
• Foot and ankle deformity limiting shoe wear.
• Knee valgus or instability.
• Pain, fatigue, falls and reduced activity.

Treatment complications

• Pin-site infection or deep infection.
• Poor regenerate, delayed union, fracture or hardware problems.
• Joint subluxation during lengthening.
• Knee, hip or ankle stiffness.
• Nerve stretch symptoms or palsy.
• Socket and skin problems after prosthetic fitting.
• Revision surgery through growth.
• Family and child treatment fatigue.

Counselling should be neutral and specific. Families should hear that reconstruction and prosthetic care can both be excellent when matched to anatomy. Avoid framing amputation as giving up or reconstruction as automatically superior. Discuss what the child is likely to experience: number of operations, therapy, pain, device time, school disruption, sport participation, prosthetic revisions, cosmesis and psychological support.

Follow-up should update prediction, function and goals. A plan made in infancy may change when foot deformity, knee instability, child preference, family capacity or technology changes. The child should increasingly participate in decisions as they mature.

Saying It in Words a Parent Will Hear

"Neutral counselling" is easy to assert and hard to do, and an examiner in a clinical station will ask you to actually say it. Three things reliably help.

Name the decision as being about function, not about keeping or losing a limb. A parent hears "amputation" as loss and "reconstruction" as repair, and that framing decides the conversation before any evidence is heard. It helps to say plainly that both routes end with the child walking, and that the question is which route gets there with the fewest operations and the most reliable foot — something like: "Both of these paths are ways of building your child a leg that works. One builds it from the foot she has; the other builds it from a prosthesis. Neither is giving up."

Give the burden as a number, because families can weigh a number. "On average, children who have the reconstruction have about four operations; children who have the amputation have about one or two. Complications are around six times more common with reconstruction." That is more use than "reconstruction is demanding", and it is the information families later say they wanted.

Say out loud what you do not yet know. In infancy the foot has not declared itself and the discrepancy prediction still carries error. Committing to a pathway on the day of diagnosis is rarely necessary, and saying "we do not have to decide this today, and here is what we are watching for" removes pressure without withholding anything.

Two further points belong in the same conversation. Where a rotationplasty is on the table, the backward-facing foot has to be described in advance and, if possible, shown — families who meet the operation only as a diagram are far less likely to accept it, and the objection is cosmetic rather than functional. And where amputation is chosen in infancy, it is worth saying that children who grow up with it generally regard it as how their leg has always been, rather than as something taken from them.

View larger

Congenital lower-limb deficiency management is a lifetime mobility plan. The clinical decision is not reconstruction versus amputation in the abstract; it is which pathway gives the child a plantigrade, braceable or prosthesis-friendly limb with the least morbidity and the best function over growth.

Amputation or rotationplasty is not a failure when it gives earlier, safer, more predictable mobility.

Structured clinical approach

Start with age, side, ambulatory status and the condition pattern. Describe each anatomical level: pelvis and hip, femur, knee, tibia/fibula, ankle, foot rays and skin. State the current and predicted discrepancy, foot reconstructability, joint stability and the family's goals. Then present a neutral pathway comparison.

Common pitfalls

• Planning from the current centimetre discrepancy alone.
• Forgetting foot-height contribution to total LLD.
• Lengthening above an unstable hip, knee or ankle.
• Ignoring foot reconstructability in fibular hemimelia.
• Naming a classification without being able to define it - Jones 1a versus 1b in particular.
• Reserving femoral imaging for the severe fibular patterns.
• Presenting prosthetic care as a failure.
• Underestimating rehabilitation and family burden.
• Not updating predictions through growth.
• Forgetting the child's own preference in later childhood.

Integrated clinical approach

"I would not decide from the discrepancy alone. I would define the anatomical deficiency, assess hip and knee stability, decide whether the foot can become plantigrade and shoeable, predict LLD at maturity, and discuss reconstruction, prosthetic or hybrid pathways with the family. The goal is reliable painless mobility with an acceptable lifetime treatment burden."

Congenital lower-limb deficiency has no single society "guideline" in the way arthroplasty does; practice is shaped by classification-based specialist consensus, prosthetic-rehabilitation standards and resource availability. The picture is genuinely global, and the right pathway shifts with what reconstruction, prosthetics and follow-up a setting can sustain.

Global epidemiology

Side-by-side practice frameworks

Registry and surveillance notes

Unlike arthroplasty, there is no implant registry for these conditions; population data come from congenital-anomaly surveillance networks such as EUROCAT (Europe), the US National Birth Defects Prevention Network and the International Clearinghouse for Birth Defects Surveillance and Research. These define prevalence and associated anomalies but not long-term functional outcomes, which still rely on specialist cohorts.

High- versus limited-resource practice variation

Several decisions in congenital lower-limb deficiency remain genuinely debated, and a strong exam candidate acknowledges the uncertainty rather than asserting a single right answer.